Stock Code: 002020 Stock Abbreviation: Jingshen Pharmaceutical Announcement No.: 2026013
Zhejiang Jingshen Pharmaceutical Co., Ltd. Announcement on Submitting Application for Issuance and Listing of Overseas Listed Shares (H Shares) to the Hong Kong Stock Exchange and Publishing Application Materials
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed in this announcement, and that there are no false records, misleading statements, or material omissions.
Zhejiang Jingshen Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") submitted an application to the Stock Exchange of Hong Kong Limited (hereinafter referred to as the "Hong Kong Stock Exchange") on February 11, 2026, for the issuance and listing of overseas listed shares (H Shares) on the Main Board of the Hong Kong Stock Exchange (hereinafter referred to as the "Proposed Issuance and Listing"), and published the application materials for the Proposed Issuance and Listing on the website of the Hong Kong Stock Exchange on the same day. These application materials were prepared and published by the Company in accordance with the requirements of the Securities and Futures Commission of Hong Kong (hereinafter referred to as the "SFC") and the Hong Kong Stock Exchange. They are in draft form and may be updated and revised from time to time. Investors should not make any investment decisions based on the information contained therein.